Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENSG · against 1,372 other Healthcare companies
Ranked #680 of 1,373 · scores higher than 51% of peers · safety percentile 51
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 50–59, including ENSG · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ENSG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.92× | 0.24× | 17% | 33% | |
| BetaLower is better · 1,320 reported | 0.66 | 0.53 | 41% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.21× | 2.62× | 16% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 676 | 108.6B USD | 51 | 66 | |
| 677 | 4.2B USD | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 44 |
| 678 | 798.5B KRW (≈$575M) | 51 | 54 |
| 679 | 15.0B CNY (≈$2.1B) | 51 | 55 |
| 680 | 10.6B USD | 51 | 64 |
| 681 | 31.3B CNY (≈$4.4B) | 50 | 65 |
| 682 | 468M USD | 50 | 40 |
| 683 | 9.1B CNY (≈$1.3B) | 50 | 32 |
| 684 | 144.1B KRW (≈$104M) | 50 | 45 |